Immunofluorescence in dermatology - 02/09/11
Abstract |
The accurate diagnosis of bullous and other immune diseases of the skin requires evaluation of clinical, histologic, and immunofluorescence findings. Immunofluorescence testing is invaluable in confirming a diagnosis that is suspected by clinical or histologic examination. This is especially true in subepidermal bullous diseases that often have overlap in the clinical and histologic findings. Direct immunofluorescence is performed on perilesional skin for patients with bullous diseases and lesional skin for patients with connective tissue diseases and vasculitis. (J Am Acad Dermatol 2001;45:803-22.) Learning objective: At the completion of this learning activity, participants should be familiar with the ideal method of obtaining immunofluorescence testing for the diagnosis of immune skin diseases and be aware of the value and limitations of immunofluorescence studies.
Le texte complet de cet article est disponible en PDF.Abbreviations : BMZ, BP, CP, DEJ, DH, DIF, DLE, EBA, HG, HSP, ICS, IIF, LAD, LCV, LE, LP, MCTD, NLE, PCT, PE, PF, PNP, PV, SCLE, SLE
Plan
Reprint requests: Diya F. Mutasim, MD, Department of Dermatology, University of Cincinnati, PO Box 670592, Cincinnati, OH 45267-0592. E-mail: mutasidf@email.uc.edu. |
Vol 45 - N° 6
P. 803-824 - décembre 2001 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?